187 related articles for article (PubMed ID: 31071153)
1. Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering.
Heitmeier MR; Hresko RC; Edwards RL; Prinsen MJ; Ilagan MXG; Odom John AR; Hruz PW
PLoS One; 2019; 14(5):e0216457. PubMed ID: 31071153
[TBL] [Abstract][Full Text] [Related]
2. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds.
Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM
PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322
[TBL] [Abstract][Full Text] [Related]
3. A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters.
Kraft TE; Heitmeier MR; Putanko M; Edwards RL; Ilagan MX; Payne MA; Autry JM; Thomas DD; Odom AR; Hruz PW
Antimicrob Agents Chemother; 2016 Dec; 60(12):7407-7414. PubMed ID: 27736766
[TBL] [Abstract][Full Text] [Related]
4. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
[TBL] [Abstract][Full Text] [Related]
5. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
Joet T; Eckstein-Ludwig U; Morin C; Krishna S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024
[TBL] [Abstract][Full Text] [Related]
6. The hexose transporter of Plasmodium falciparum is a worthy drug target.
Joët T; Krishna S
Acta Trop; 2004 Feb; 89(3):371-4. PubMed ID: 14744563
[TBL] [Abstract][Full Text] [Related]
7. Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT).
Ionita M; Krishna S; Léo PM; Morin C; Patel AP
Bioorg Med Chem Lett; 2007 Sep; 17(17):4934-7. PubMed ID: 17587575
[TBL] [Abstract][Full Text] [Related]
8. Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality.
Slavic K; Straschil U; Reininger L; Doerig C; Morin C; Tewari R; Krishna S
Mol Microbiol; 2010 Mar; 75(6):1402-13. PubMed ID: 20132450
[TBL] [Abstract][Full Text] [Related]
9. Docking, QM/MM, and molecular dynamics simulations of the hexose transporter from Plasmodium falciparum (PfHT).
Fonseca AL; Nunes RR; Braga VM; Comar M; Alves RJ; Varotti Fde P; Taranto AG
J Mol Graph Model; 2016 May; 66():174-86. PubMed ID: 27131282
[TBL] [Abstract][Full Text] [Related]
10. The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir.
Kraft TE; Armstrong C; Heitmeier MR; Odom AR; Hruz PW
Antimicrob Agents Chemother; 2015 Oct; 59(10):6203-9. PubMed ID: 26248369
[TBL] [Abstract][Full Text] [Related]
11. New antimalarial targets: the example of glucose transport.
Patel AP; Staines HM; Krishna S
Travel Med Infect Dis; 2008; 6(1-2):58-66. PubMed ID: 18342277
[TBL] [Abstract][Full Text] [Related]
12. Isoform-selective inhibition of facilitative glucose transporters: elucidation of the molecular mechanism of HIV protease inhibitor binding.
Hresko RC; Kraft TE; Tzekov A; Wildman SA; Hruz PW
J Biol Chem; 2014 Jun; 289(23):16100-13. PubMed ID: 24706759
[TBL] [Abstract][Full Text] [Related]
13. Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites.
Frame IJ; Deniskin R; Rinderspacher A; Katz F; Deng SX; Moir RD; Adjalley SH; Coburn-Flynn O; Fidock DA; Willis IM; Landry DW; Akabas MH
ACS Chem Biol; 2015 Mar; 10(3):775-83. PubMed ID: 25602169
[TBL] [Abstract][Full Text] [Related]
14. Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives.
Fayolle M; Ionita M; Krishna S; Morin C; Patel AP
Bioorg Med Chem Lett; 2006 Mar; 16(5):1267-71. PubMed ID: 16361099
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor.
Joët T; Chotivanich K; Silamut K; Patel AP; Morin C; Krishna S
Biochem J; 2004 Aug; 381(Pt 3):905-9. PubMed ID: 15107012
[TBL] [Abstract][Full Text] [Related]
16. An expression system to screen for inhibitors of parasite glucose transporters.
Feistel T; Hodson CA; Peyton DH; Landfear SM
Mol Biochem Parasitol; 2008 Nov; 162(1):71-6. PubMed ID: 18708094
[TBL] [Abstract][Full Text] [Related]
17. Identification, expression and characterisation of a Babesia bovis hexose transporter.
Derbyshire ET; Franssen FJ; de Vries E; Morin C; Woodrow CJ; Krishna S; Staines HM
Mol Biochem Parasitol; 2008 Oct; 161(2):124-9. PubMed ID: 18638508
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
19. Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle.
Slavic K; Delves MJ; Prudêncio M; Talman AM; Straschil U; Derbyshire ET; Xu Z; Sinden RE; Mota MM; Morin C; Tewari R; Krishna S; Staines HM
Antimicrob Agents Chemother; 2011 Jun; 55(6):2824-30. PubMed ID: 21402842
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum.
Jiang X; Yuan Y; Huang J; Zhang S; Luo S; Wang N; Pu D; Zhao N; Tang Q; Hirata K; Yang X; Jiao Y; Sakata-Kato T; Wu JW; Yan C; Kato N; Yin H; Yan N
Cell; 2020 Oct; 183(1):258-268.e12. PubMed ID: 32860739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
